| " Women with severe postpartum hemorrhage have a decreased endogenous thrombin potential before delivery": reply C de Moreuil, Y Dargaud, B Pan-Petesch Journal of thrombosis and haemostasis: JTH 22 (3), 879-880, 2024 | | 2024 |
| A case of Glanzmann's thrombasthenia successfully treated with recombinant factor viia during a surgical procedure: observations on the monitoring and the mechanism of action … Y Dargaud, JC Bordet, MC Trzeciak, C Vinciguerra, C Negrier Haematologica 91 (6_Suppl), ECR20-ECR20, 2006 | 44 | 2006 |
| A focus on dominant negative variants in a series of 170 heterozygous FXI‐deficient patients P de Mazancourt, F Quélin, C Flaujac, E de Raucourt, B Guillet, ... Haemophilia 29 (4), 1113-1120, 2023 | | 2023 |
| A hypoxic environment attenuates exercise-induced procoagulant changes due to decreased platelet activation CH Kicken, LN van der Vorm, S Zwaveling, E Schoenmaker, JA Remijn, ... TH Open 3 (03), e216-e226, 2019 | 7 | 2019 |
| A new paradigm for personalized prophylaxis for patients with severe haemophilia A X Delavenne, E Ollier, A Lienhart, Y Dargaud Haemophilia 26 (2), 228-235, 2020 | 24 | 2020 |
| A novel hereditary bleeding disorder characterized by low thrombin generation caused by factor v inhibition Y Dargaud, T Lindhout, RJ Wagenvoord, E Castoldi, T Hackeng, ... JOURNAL OF THROMBOSIS AND HAEMOSTASIS 9, 224-224, 2011 | | 2011 |
| A risk score for the management of pregnant women with increased risk of venous thromboembolism: a multicentre prospective study Y Dargaud, L Rugeri, MC Vergnes, B Arnuti, P Miranda, C Negrier, ... British journal of haematology 145 (6), 825-835, 2009 | 106 | 2009 |
| A single‐centre study of management of pregnant women with von Willebrand disease Z Xu, Y Dargaud, V Chamouard, S Le Quellec, A Lienhart, S Meunier, ... Haemophilia 25 (1), e54-e57, 2019 | 6 | 2019 |
| Achievements, challenges and unmet needs for haemophilia patients with inhibitors: report from a symposium in Paris, France on 20 November 2014 Y Dargaud, A Pavlova, S Lacroix‐Desmazes, K Fischer, M Soucie, ... Haemophilia 22, 1-24, 2016 | 21 | 2016 |
| Acquired factor V deficiency: a rare bleeding disorder with variable clinical presentations M Alcantara, S Ducastelle, L Rugeri, Y Dargaud La Revue de Medecine Interne 32 (5), e59-61, 2010 | 4 | 2010 |
| Acquired Glanzmann's thrombasthenia associated with acute lymphoblastic leukemia JM André, C Galambrun, MC Trzeciak, Y Dargaud, C Kaplan-Gouet, ... Journal of Pediatric Hematology/Oncology 27 (10), 554-557, 2005 | 20 | 2005 |
| Activated factor X cleaves factor VIII at arginine 562, limiting its cofactor efficiency JL Plantier, V Rolli, C Ducasse, Y Dargaud, N Enjolras, H Boukerche, ... Journal of Thrombosis and Haemostasis 8 (2), 286-293, 2010 | 26 | 2010 |
| Actualités cliniques X LELEU, AS MOREAU, P ROUSSELOT, Y DARGAUD Hématologie 13 (2), 71, 2007 | | 2007 |
| Actualités cliniques Y DARGAUD, V ECLACHE, P ROUSSELOT, X LELEU, É LIPPERT, ... Hématologie 13 (4), 219, 2007 | | 2007 |
| Adeno-Associated Virus Mediated Gene Transfer with Hyperfunctional FIX-E410H Variant Improves Mean Factor IX Activity Levels in Hemophilia B Mice S Le Quellec, AP Dane, C Negrier, Y Dargaud, AC Nathwani, N Enjolras Blood 130, 4610, 2017 | | 2017 |
| Age is a Risk Factor for Poor Knowledge About Venous Thromboembolism Treatment J Catella, E Rivoire, I Abejiou, S Quiquandon, H Desmurs-Clavel, ... Clinical and Applied Thrombosis/Hemostasis 30, 10760296241276527, 2024 | | 2024 |
| Alloimmunization in Congenital Deficiencies of Platelet Surface Glycoproteins: Focus on Glanzmann's Thrombasthenia and Bernard–Soulier's Syndrome MC Poon, R d'Oiron Seminars in thrombosis and hemostasis 44 (06), 604-614, 2018 | 31 | 2018 |
| ALN-AT3: an RNAi therapeutic targeting antithrombin for the treatment of hemophilia A Sehgal, J Qin, T Racie, S Barros, B Sorensen, L Ivanciu, R Camire, ... Haemophilia 20, 82-82, 2014 | 1 | 2014 |
| An in Vitro Pilot Study of the Role of Factor IX As an Alternative to Bypassing Agents in the Treatment of Breakthrough Bleeds in Patients with Hemophilia a and Inhibitors … M Janbain, L Josset, C Nougier, CA Leissinger, R Ksayer, Y Dargaud Blood 142, 5475, 2023 | | 2023 |
| An RNAi therapeutic targeting antithrombin to rebalance the coagulation system and promote hemostasis in hemophilia A Sehgal, S Barros, L Ivanciu, B Cooley, J Qin, T Racie, J Hettinger, ... Nature medicine 21 (5), 492-497, 2015 | 305 | 2015 |
